Literature DB >> 31880997

Correlation Between Electrophysiological Changes and Outcomes of Vocal Cord Function in 1764 Recurrent Laryngeal Nerves with Visual Integrity During Thyroidectomy.

Qianqian Yuan1, Gaosong Wu1, Jinxuan Hou1, Xing Liao1, Yiqin Liao1, Feng-Yu Chiang2,3.   

Abstract

Background: The correlation between the injured recurrent laryngeal nerve (RLN) with incomplete loss of signal (LOS) and the outcomes of vocal cord function is still not well understood. This large cohort validation study was aimed to evaluate the effectiveness of the warning criterion, the reduction of the R2p/R2d ratio, in neuromonitoring during thyroidectomy.
Methods: A total of 1108 consecutive patients (1764 nerves) with normal vocal cord function undergoing monitored thyroidectomy were included. Standardized intraoperative neuromonitoring procedures were strictly followed, after complete dissection of RLN, the exposed RLN was routinely stimulated at the lowest proximal end (R2p signal) and the most distal end near the laryngeal entry point (R2d signal). If the reduction of the R2p/R2d ratio (([R2d - R2p]/R2d) × 100%) reached >20%, the whole exposed RLN would be checked to pinpoint the injured area of the nerve.
Results: Visual anatomical integrity of the RLN was ensured in all 1764 nerves. Eighteen nerves had complete LOS, and the other 97 nerves had incomplete LOS where the reduction of the R2p/R2d ratio ranged from 21% to 84%. Postoperative temporary vocal cord paralysis (VCP) was noted in 11 (61.1%) RLNs with complete LOS and 16 (16.5%) RLNs with incomplete LOS, where the reduction of the R2p/R2d ratio ranged from 63% to 84%. The positive predictive value of a R2p/R2d ratio >63% for postoperative VCP was 79.4%. Conclusions: Testing and comparing the R2p and R2d signals were useful to detect RLN neurophysiologic injury, elucidating the mechanism of nerve injury and predicting vocal cord function. Determining R2p-R2d was found to be essential and can be applied in routine neuromonitoring thyroidectomy.

Entities:  

Keywords:  intraoperative neuromonitoring; recurrent laryngeal nerve; surgery; thyroid

Mesh:

Year:  2020        PMID: 31880997     DOI: 10.1089/thy.2019.0361

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  5 in total

1.  Is There Any Reliable Predictor of Functional Recovery Following Post-thyroidectomy Vocal Fold Paralysis?

Authors:  Luca Revelli; Pierpaolo Gallucci; Maria Raffaella Marchese; Nikolaos Voloudakis; Sofia Di Lorenzo; Claudio Montuori; Lucia D'Alatri; Francesco Pennestri; Carmela De Crea; Marco Raffaelli
Journal:  World J Surg       Date:  2022-10-12       Impact factor: 3.282

2.  Total thyroidectomy versus hemithyroidectomy with intraoperative radiofrequency ablation for unilateral thyroid cancer with contralateral nodules: A propensity score matching study.

Authors:  Qianqian Yuan; Lewei Zheng; Jinxuan Hou; Rui Zhou; Gaoran Xu; Chengxin Li; Gaosong Wu
Journal:  J Otolaryngol Head Neck Surg       Date:  2022-06-11

3.  The area under the waveform of electromyography for monitoring the external branches of the superior laryngeal nerve during thyroid surgery.

Authors:  Yishen Zhao; Zihan Zhao; Tie Wang; Daqi Zhang; Gianlorenzo Dionigi; Hui Sun
Journal:  Gland Surg       Date:  2021-01

4.  Comparison of Surgical Complications Rates Between LigaSure Small Jaw and Clamp-and-Tie Hemostatic Technique in 1,000 Neuro-Monitored Thyroidectomies.

Authors:  Cheng-Hsin Liu; Chih-Chun Wang; Che-Wei Wu; Yi-Chu Lin; I-Cheng Lu; Pi-Ying Chang; Ching-Feng Lien; Chien-Chung Wang; Tzer-Zen Hwang; Tzu-Yen Huang; Feng-Yu Chiang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-07       Impact factor: 5.555

5.  Correlation between Electrophysiological Change and Facial Function in Parotid Surgery Patients.

Authors:  Feng-Yu Chiang; Chih-Chun Wang; Che-Wei Wu; I-Cheng Lu; Pi-Ying Chang; Yi-Chu Lin; Ching-Feng Lien; Chien-Chung Wang; Tzu-Yen Huang; Tzer-Zen Hwang
Journal:  J Clin Med       Date:  2021-12-07       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.